Back to Research

Organization profile

Citus

Citus is a Swiss biotechnology startup and ETH Zurich spin-off that specializes in non-invasive skin health analysis. The company uses advanced diagnostic technology and a comprehensive database to provide real-time biological age assessments and personalized skincare solutions for the longevity market.46

Dübendorf, SwitzerlandFounded 2023

Overview

1. Executive Summary (Confidence: Moderate)

CITUS is an emerging high-tech venture in the Swiss longevity ecosystem, founded in 2023 as a spin-off from the prestigious ETH Zurich. The company’s core mission is to provide the world’s most accurate skin health analysis by bridging the gap between non-invasive diagnostics and biological longevity science.[47] CITUS has already demonstrated technical and financial traction, securing CHF 375,000 in convertible loan funding in October 2023 to advance its skin health platform. By offering real-time assessments of biological age through skin biomarkers, the startup empowers both consumers and professional wellness providers to optimize health, beauty, and long-term vitality through data-driven personalization.

This is an extract of the full organization profile. To access the full company profile, .

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.